Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1973 May;118(5):38–55.

Current transfusion therapy.

E Hinkes, R O Steffen
PMCID: PMC1455048  PMID: 4573217

Full text

PDF
38

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLEN J. G., SYKES C., ENERSON D. M., MOULDER P. V., ELGHAMMER R. M., GROSSMAN B. J., McKEEN C. L., GALLUZZI N. J. Homologous serum jaundice and its relation to methods of plasma storage. J Am Med Assoc. 1950 Nov 25;144(13):1069–1074. doi: 10.1001/jama.1950.02920130021005. [DOI] [PubMed] [Google Scholar]
  2. ALSEVER J. B., CHERKIN A., BARGER J. D. A DEFENSE OF THE GLASS TRANSFUSION CONTAINER. Ariz Med. 1965 May;22:375–381. [PubMed] [Google Scholar]
  3. Abildgaard C. F., Simone J. V., Corrigan J. J., Seeler R. A., Edelstein G., Vanderheiden J., Schulman I. Treatment of hemophilia with glycine-precipitated factor 8. N Engl J Med. 1966 Sep 1;275(9):471–475. doi: 10.1056/NEJM196609012750904. [DOI] [PubMed] [Google Scholar]
  4. Akerblom O., Jameson S., Högman C. F., Wibell L. Autologous transfusions in uraemic patients. Lancet. 1970 Aug 22;2(7669):385–387. doi: 10.1016/s0140-6736(70)90003-6. [DOI] [PubMed] [Google Scholar]
  5. Akerblom O., de Verdier C. H., Finnson M., Garby L., Högman C. F., Johansson S. G. Further studies on the effect of adenine in blood preservation. Transfusion. 1967 Jan-Feb;7(1):1–9. doi: 10.1111/j.1537-2995.1967.tb04823.x. [DOI] [PubMed] [Google Scholar]
  6. Allen J. G. Autologous transfusion. JAMA. 1971 Jul 5;217(1):80–80. [PubMed] [Google Scholar]
  7. Almeida J. D., Rubenstein D., Stott E. J. New antigen-antibody system in Australia-antigen-positive hepatitis. Lancet. 1971 Dec 4;2(7736):1225–1227. doi: 10.1016/s0140-6736(71)90543-5. [DOI] [PubMed] [Google Scholar]
  8. Anscombe A. R. Surgery in haemophilia and allied disorders. Ann R Coll Surg Engl. 1970 Sep;47(3):125–138. [PMC free article] [PubMed] [Google Scholar]
  9. Ascari W. Q., Jolly P. C., Thomas P. A. Autologous blood transfusion in pulmonary surgery. Transfusion. 1968 Mar-Apr;8(2):111–115. doi: 10.1111/j.1537-2995.1968.tb02405.x. [DOI] [PubMed] [Google Scholar]
  10. BIGGS R., RUSH B. M., MACFARLANE R. G., MATTHEWS J. M., JOHNSTONE F. C., HAYTON-WILLIAMS D. S. FURTHER EXPERIENCE IN USE OF HUMAN ANTIHAEMOPHILIC GLOBULIN (H.A.H.G.) FOR THE CONTROL OF BLEEDING AFTER DENTAL EXTRACTION IN HAEMOPHILIC PATIENTS: A REPORT TO THE MEDICAL RESEARCH COUNCIL'S WORKING PARTY ON HUMAN ANTIHAEOMOPHILIC GLOBULIN. Lancet. 1965 May 8;1(7393):969–974. doi: 10.1016/s0140-6736(65)91213-4. [DOI] [PubMed] [Google Scholar]
  11. BLUMBERG B. S., ALTER H. J., VISNICH S. A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA. 1965 Feb 15;191:541–546. doi: 10.1001/jama.1965.03080070025007. [DOI] [PubMed] [Google Scholar]
  12. BRITTINGHAM T. E. Immunologic studies on leukocytes. Vox Sang. 1957 Sep;2(4):242–248. doi: 10.1111/j.1423-0410.1957.tb03699.x. [DOI] [PubMed] [Google Scholar]
  13. Becker S. M., Pribor H. C., Remington M. Routine use of frozen blood in a community hospital. Economic dream or reality? Transfusion. 1971 Sep-Oct;11(5):292–295. doi: 10.1111/j.1537-2995.1971.tb04417.x. [DOI] [PubMed] [Google Scholar]
  14. Berg R., Björling H., Berntsen K., Espmark A. Recovery of Australia antigen from human plasma products separated by a modified Cohn fractionation. Vox Sang. 1972 Jan;22(1):1–13. doi: 10.1111/j.1423-0410.1972.tb03961.x. [DOI] [PubMed] [Google Scholar]
  15. Beutler E., Meul A., Wood L. A. Depletion and regeneration of 2,3-diphosphoglyceric acid in stored red blood cells. Transfusion. 1969 May-Jun;9(3):109–115. doi: 10.1111/j.1537-2995.1969.tb05527.x. [DOI] [PubMed] [Google Scholar]
  16. Blumberg B. S., Sutnick A. I., London W. T., Millman I. Australia antigen and hepatitis. N Engl J Med. 1970 Aug 13;283(7):349–354. doi: 10.1056/NEJM197008132830707. [DOI] [PubMed] [Google Scholar]
  17. Breen F. A., Jr, Tullis J. L. Prothrombin concentrates in treatment of Christmas disease and allied disorders. JAMA. 1969 Jun 9;208(10):1848–1852. [PubMed] [Google Scholar]
  18. Buchholz D. H., Young V. M., Friedman N. R., Reilly J. A., Mardiney M. R., Jr Bacterial proliferation in platelet products stored at room temperature. Transfusion-induced Enterobacter sepsis. N Engl J Med. 1971 Aug 19;285(8):429–433. doi: 10.1056/NEJM197108192850803. [DOI] [PubMed] [Google Scholar]
  19. CHAPLIN H., Jr, BRITTINGHAM T. E., CASSELL M. Methods for preparation of suspensions of buffy coat-poor red blood cells for transfusion; including a report of 50 transfusions of suspensions of buffy coat-poor red blood cells prepared by a dextran sedimentation method. Am J Clin Pathol. 1959 May;31(5):373–383. doi: 10.1093/ajcp/31.5.373. [DOI] [PubMed] [Google Scholar]
  20. Caseley J., Moses V. K., Lichter E. A., Jonasson O. Isoimmunization of hemodialysis patients: leukocyte-poor versus whole blood transfusions. Transplant Proc. 1971 Mar;3(1):365–367. [PubMed] [Google Scholar]
  21. Chalmers T. C., Alter H. J. Management of the asymptomatic carrier of the hepatitis-associated (Australia antigen. Tentative considerations of the clinical and public-health aspects. N Engl J Med. 1971 Sep 9;285(11):613–617. doi: 10.1056/NEJM197109092851106. [DOI] [PubMed] [Google Scholar]
  22. Chaplin H., Jr Packed red blood cells. N Engl J Med. 1969 Aug 14;281(7):364–367. doi: 10.1056/NEJM196908142810707. [DOI] [PubMed] [Google Scholar]
  23. Cherubin C. E., Prince A. M. Serum hepatitis specific antigen (SH) in commercial and volunteer sources of blood. Transfusion. 1971 Jan-Feb;11(1):25–27. doi: 10.1111/j.1537-2995.1971.tb04370.x. [DOI] [PubMed] [Google Scholar]
  24. Cooke J. V., Holland P. V., Shulman N. R. Cryoprecipitate concentrates of factor 8 for surgery in hemophiliacs. Ann Intern Med. 1968 Jan;68(1):39–47. [PubMed] [Google Scholar]
  25. Cuello L., Vázquez E., Raffucci F. L., Pérez V. Autologous blood transfusion in cardiovascular surgery. Transfusion. 1967 Jul-Aug;7(4):309–315. doi: 10.1111/j.1537-2995.1967.tb05524.x. [DOI] [PubMed] [Google Scholar]
  26. DARNBOROUGH J. The anti-A and anti-B antibody content of pooled plasma. J Clin Pathol. 1963 Jan;16:74–78. doi: 10.1136/jcp.16.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Dallman P. R., Pool J. G. Treatment of hemophilia with factor 8 concentrates. N Engl J Med. 1968 Jan 25;278(4):199–202. doi: 10.1056/NEJM196801252780406. [DOI] [PubMed] [Google Scholar]
  28. Davis M. A., Peters R. L., Redeker A. G., Reynolds T. B. Appraisal of the mortality in acute fulminant viral hepatitis. N Engl J Med. 1968 Jun 6;278(23):1248–1253. doi: 10.1056/NEJM196806062782302. [DOI] [PubMed] [Google Scholar]
  29. Dawson R. B., Jr, Kocholaty W. F., Gray J. L. Hemoglobin function and 2,3-DPG levels of blood stored at 4 C in ACD and CPD: pH effect. Transfusion. 1970 Nov-Dec;10(6):299–304. doi: 10.1111/j.1537-2995.1970.tb00747.x. [DOI] [PubMed] [Google Scholar]
  30. Djerassi I., Farber S., Roy A., Cavins J. Preparation and in vivo circulation of human platelets preserved with combined dimethylsulfoxide and dextrose. Transfusion. 1966 Nov-Dec;6(6):572–576. doi: 10.1111/j.1537-2995.1966.tb04780.x. [DOI] [PubMed] [Google Scholar]
  31. Djerassi I., Kim J. S., Mitrakul C., Suvansri U., Ciesielka W. Filtration leukopheresis for separation and concentration of transfusable amounts of normal human granulocytes. J Med. 1970;1(6):358–364. [PubMed] [Google Scholar]
  32. Djerassi I., Roy A., Kim J., Cavins J. Dimethylacetamide, a new cryoprotective agent for platelets. Transfusion. 1971 Mar-Apr;11(2):72–76. doi: 10.1111/j.1537-2995.1971.tb04379.x. [DOI] [PubMed] [Google Scholar]
  33. Elston R. C. Inventory levels for a hospital blood bank under the assumption of 28-day shelf life. Transfusion. 1968 Jan-Feb;8(1):19–23. doi: 10.1111/j.1537-2995.1968.tb02381.x. [DOI] [PubMed] [Google Scholar]
  34. Eyre H. J., Goldstein I. M., Perry S., Graw R. G., Jr Leukocyte transfusions: function of transfused granulocytes from donors with chronic myelocytic leukemia. Blood. 1970 Oct;36(4):432–442. [PubMed] [Google Scholar]
  35. George J. N., Breckenridge R. T. The use of facoor VIII and factor IX concentrates during surgery. JAMA. 1970 Nov 30;214(9):1673–1676. [PubMed] [Google Scholar]
  36. Ginsberg A. L., Conrad M. E., Bancroft W. H., Ling C. M., Overby L. R. Prevention of endemic HAA-positive hepatitis with gamma globulin. Use of a simple radioimmune assay to detect HAA. N Engl J Med. 1972 Mar 16;286(11):562–566. doi: 10.1056/NEJM197203162861102. [DOI] [PubMed] [Google Scholar]
  37. Gocke D. J. A prospective study of posttransfusion hepatitis. The role of Australia Antigen. JAMA. 1972 Feb 28;219(9):1165–1170. [PubMed] [Google Scholar]
  38. Goldfinger D., McGinniss M. H. Rh-incompatible platelet transfusions--risks and consequences of sensitizing immunosuppressed patients. N Engl J Med. 1971 Apr 29;284(17):942–944. doi: 10.1056/NEJM197104292841704. [DOI] [PubMed] [Google Scholar]
  39. Graw R. G., Jr, Buckner C. D., Eisel R. Plasma exchange transfusion for hepatic coma. New technic. Transfusion. 1970 Jan-Feb;10(1):26–32. doi: 10.1111/j.1537-2995.1970.tb00699.x. [DOI] [PubMed] [Google Scholar]
  40. Graw R. G., Jr, Herzig G. P., Eisel R. J., Perry S. Leukocyte and platelet collection from normal donors with the continuous flow blood cell separator. Transfusion. 1971 Mar-Apr;11(2):94–101. doi: 10.1111/j.1537-2995.1971.tb04383.x. [DOI] [PubMed] [Google Scholar]
  41. Gray J. A. The use of gamma-globulin. Practitioner. 1971 Apr;206(234):494–500. [PubMed] [Google Scholar]
  42. Green D., Smith N. J. Hemophilia. Current concepts in management. Med Clin North Am. 1972 Jan;56(1):105–117. doi: 10.1016/s0025-7125(16)32426-9. [DOI] [PubMed] [Google Scholar]
  43. Green D. Therapeutic use of factor VIII. N Engl J Med. 1972 Oct 19;287(16):822–822. [PubMed] [Google Scholar]
  44. Greenwalt T. J., Perry S. Preservation and utilization of the components of human blood. Prog Hematol. 1969;6:148–180. [PubMed] [Google Scholar]
  45. Grindon A. J., Holland P. V., Schmidt P. J. Posttransfusion hepatitis. Am Heart J. 1967 Nov;74(5):591–594. doi: 10.1016/0002-8703(67)90498-x. [DOI] [PubMed] [Google Scholar]
  46. Hampton J. W., Garrison D. Fibrinogen and fibrin-stabilizing factor. Med Clin North Am. 1972 Jan;56(1):133–143. doi: 10.1016/s0025-7125(16)32429-4. [DOI] [PubMed] [Google Scholar]
  47. Hansson B. G., Johnsson T. Improved technique for detecting Australia antigen by immunoelectroosmophoresis. Vox Sang. 1971 Dec;21(6):531–539. doi: 10.1111/j.1423-0410.1971.tb04812.x. [DOI] [PubMed] [Google Scholar]
  48. Haradin A. R., Weed R. I., Reed C. F. Changes in physical properties of stored erythrocytes relationship to survival in vivo. Transfusion. 1969 Sep-Oct;9(5):229–237. doi: 10.1111/j.1537-2995.1969.tb04929.x. [DOI] [PubMed] [Google Scholar]
  49. Hattersley P. G. Cryoprecipitates in place of fibrinogen. N Engl J Med. 1971 Jul 8;285(2):120–120. doi: 10.1056/nejm197107082850215. [DOI] [PubMed] [Google Scholar]
  50. Hattersley P. G., Dimick M. L. Cryoprecipitates in treatment of congenital fibrinogen deficiency. Case report. Transfusion. 1969 Sep-Oct;9(5):261–264. doi: 10.1111/j.1537-2995.1969.tb04934.x. [DOI] [PubMed] [Google Scholar]
  51. Hellerstein L. J., Deykin D. Hepatitis after Konyne administration. N Engl J Med. 1971 May 6;284(18):1039–1040. [PubMed] [Google Scholar]
  52. Herzig G. P., Root R. K., Graw R. G., Jr Granulocyte collection by continuous-flow filtration leukapheresis. Blood. 1972 Apr;39(4):554–567. [PubMed] [Google Scholar]
  53. Hirschman R. J., Itscoitz S. B., Shulman N. R. Prophylactic treatment of factor VIII deficiency. Blood. 1970 Feb;35(2):189–194. [PubMed] [Google Scholar]
  54. Hoag M. S., Johnson F. F., Robinson J. A., Aggeler P. M. Treatment of hemophilia B with a new clotting-factor concentrate. N Engl J Med. 1969 Mar 13;280(11):581–586. doi: 10.1056/NEJM196903132801103. [DOI] [PubMed] [Google Scholar]
  55. Honig G. R., Forman E. N., Johnston C. A., Seeler R. A., Abildgaard C. F., Schulman I. Administration of single doses of AHF (factor VIII) concentrates in the treatment of hemophilic hemarthroses. Pediatrics. 1969 Jan;43(1):26–33. [PubMed] [Google Scholar]
  56. Hudson L. W., Glimp H. A., Little C. O., Woolfolk P. G. Effect of level and solubility of soybean protein on its utilization by young lambs. J Anim Sci. 1969 Feb;28(2):279–282. doi: 10.2527/jas1969.282279x. [DOI] [PubMed] [Google Scholar]
  57. Huggins C. E. Frozen blood: principles of practical preservation. Monogr Surg Sci. 1966 Sep;3(3):133–173. [PubMed] [Google Scholar]
  58. Hummer G. J. Advances in blood component therapy. Anesthesiology. 1971 Apr;34(4):309–311. doi: 10.1097/00000542-197104000-00004. [DOI] [PubMed] [Google Scholar]
  59. Kasper C. K., Dietrich S. L., Rapaport S. I. Hemophilia prophylaxis with factor VIII concentrate. Arch Intern Med. 1970 Jun;125(6):1004–1009. [PubMed] [Google Scholar]
  60. Kasper C. K. Surgical operation in hemophilia B. Use of factor IX concentrate. Calif Med. 1970 Jul;113(1):4–8. [PMC free article] [PubMed] [Google Scholar]
  61. Kattlove H. E., Alexander B. The effect of cold on platelets. I. Cold-induced platelet aggregation. Blood. 1971 Jul;38(1):39–48. [PubMed] [Google Scholar]
  62. Katz A. J., Tilton R. C. Sterility of platelet concentrates stored at 25 C. Transfusion. 1970 Nov-Dec;10(6):329–330. doi: 10.1111/j.1537-2995.1970.tb00754.x. [DOI] [PubMed] [Google Scholar]
  63. Katz R., Rodriguez J., Ward R. Post-transfusion hepatitis--effect of modified gamma globulin added to blood in vitro. N Engl J Med. 1971 Oct 21;285(17):925–932. doi: 10.1056/NEJM197110212851701. [DOI] [PubMed] [Google Scholar]
  64. Klebanoff G. Early clinical experience with a disposable unit for the intraoperative salvage and reinfusion of blood loss (intraoperative autotransfusion). Am J Surg. 1970 Dec;120(6):718–722. doi: 10.1016/s0002-9610(70)90066-8. [DOI] [PubMed] [Google Scholar]
  65. Kliman A. No hepatitis after packed red cells? N Engl J Med. 1968 Dec 5;279(23):1290–1290. doi: 10.1056/NEJM196812052792318. [DOI] [PubMed] [Google Scholar]
  66. LEVIN R. H., WHANG J., TJIO J. H., CARBONE P. P., FREI E., 3rd, FREIREICH E. J. PERSISTENT MITOSIS OF TRANSFUSED HOMOLOGOUS LEUKOCYTES IN CHILDREN RECEIVING ANTILEUKEMIC THERAPY. Science. 1963 Dec 6;142(3597):1305–1311. doi: 10.1126/science.142.3597.1305. [DOI] [PubMed] [Google Scholar]
  67. La Celle P. L. Alteration of deformability of the erythrocyte membrane in stored blood. Transfusion. 1969 Sep-Oct;9(5):238–245. doi: 10.1111/j.1537-2995.1969.tb04930.x. [DOI] [PubMed] [Google Scholar]
  68. MCINTYRE H., BARRETT K. E., ISRAUELS M. C., WILKINSON J. F. DENTAL TREATMENT IN THE HAEMOPHILIA SYNDROME. Lancet. 1964 Mar 14;1(7333):584–585. doi: 10.1016/s0140-6736(64)91332-7. [DOI] [PubMed] [Google Scholar]
  69. MIRICK G. S., WARD R., MCCOLLUM R. W. MODIFICATION OF POST-TRANSFUSION HEPATITIS BY GAMMA GLOBULIN. N Engl J Med. 1965 Jul 8;273:59–65. doi: 10.1056/NEJM196507082730201. [DOI] [PubMed] [Google Scholar]
  70. Mainwaring R. L., Brueckner G. G. Fibrinogen-transmitted hepatitis; a controlled study. JAMA. 1966 Feb 7;195(6):437–441. [PubMed] [Google Scholar]
  71. Marcus A. J. Platelet function (first of three parts). N Engl J Med. 1969 May 29;280(22):1213–1220. doi: 10.1056/NEJM196905292802206. [DOI] [PubMed] [Google Scholar]
  72. Mason D. Y., Ingram G. I. Management of the hereditary coagulation disorders. Semin Hematol. 1971 Apr;8(2):158–188. [PubMed] [Google Scholar]
  73. Mazza J. J., Bowie E. J., Hagedorn A. B., Didisheim P., Taswell H. F., Peterson L. F., Owen C. A., Jr Antihemophilic factor 8 in hemophilia. Use of concentrates to permit major surgery. JAMA. 1970 Mar 16;211(11):1818–1823. doi: 10.1001/jama.211.11.1818. [DOI] [PubMed] [Google Scholar]
  74. Miller R. D., Robbins T. O., Tong M. J., Barton S. L. Coagulation defects associated with massive blood transfusions. Ann Surg. 1971 Nov;174(5):794–801. doi: 10.1097/00000658-197111000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Moss G. S., Valeri C. R., Brodine C. E. Clinical experience with the use of frozen blood in combat casualties. N Engl J Med. 1968 Apr 4;278(14):747–752. doi: 10.1056/NEJM196804042781401. [DOI] [PubMed] [Google Scholar]
  76. Mourad N. Effect of prolonged storage on erythrocyte enzymes. Transfusion. 1969 May-Jun;9(3):141–142. doi: 10.1111/j.1537-2995.1969.tb05532.x. [DOI] [PubMed] [Google Scholar]
  77. Murphy S., Gardner F. H. Effect of storage temperature on maintenance of platelet viability--deleterious effect of refrigerated storage. N Engl J Med. 1969 May 15;280(20):1094–1098. doi: 10.1056/NEJM196905152802004. [DOI] [PubMed] [Google Scholar]
  78. Orlina A. R., Josephson A. M. Comparative viability of blood stored in ACD and CPD. Transfusion. 1969 Mar-Apr;9(2):62–69. doi: 10.1111/j.1537-2995.1969.tb04918.x. [DOI] [PubMed] [Google Scholar]
  79. Oski F. A., Travis S. F., Miller L. D., Delivoria-Papadopoulos M., Cannon E. The in vitro restoration of red cell 2,3-diphosphoglycerate levels in banked blood. Blood. 1971 Jan;37(1):52–58. [PubMed] [Google Scholar]
  80. PAYNE R., ROLFS M. R. Further observations on leukoagglutinin transfusion reactions in women: with special reference to leukoagglutinin transfusion reactions in women. Am J Med. 1960 Sep;29:449–458. doi: 10.1016/0002-9343(60)90041-3. [DOI] [PubMed] [Google Scholar]
  81. PAYNE R. The development and persistence of leukoagglutinins in parous women. Blood. 1962 Apr;19:411–424. [PubMed] [Google Scholar]
  82. POOL J. G., ROBINSON J. Observations on plasma banking and transfusion procedures for haemophilic patients using a quantitative assay for antihaemophilic globulin (AHG). Br J Haematol. 1959 Jan;5(1):24–30. doi: 10.1111/j.1365-2141.1959.tb04010.x. [DOI] [PubMed] [Google Scholar]
  83. Packham M. A., Mustard J. F. Platelet reactions. Semin Hematol. 1971 Jan;8(1):30–64. [PubMed] [Google Scholar]
  84. Pathak U. N., Stewart D. B. Autotransfusion in ruptured ectopic pregnancy. Lancet. 1970 May 9;1(7654):961–964. doi: 10.1016/s0140-6736(70)91094-9. [DOI] [PubMed] [Google Scholar]
  85. Peddle L. J., Josephson J. E., Lawton A. Auto-donation in the management of placenta previa and erythroblastosis in a pregnancy complicated by Gerbich iso-immunization. Vox Sang. 1970 Jun;18(6):547–550. doi: 10.1111/j.1423-0410.1970.tb02187.x. [DOI] [PubMed] [Google Scholar]
  86. Pert J. H., Zucker M. B., Lundberg A., Yankee R., Hendersen E. Recent advances in preparation of platelet concentrates from ACD and CPD blood. Vox Sang. 1967 Jul;13(1):119–126. [PubMed] [Google Scholar]
  87. Pollock T. M. Human immunoglobulin in prophylaxis. Br Med Bull. 1969 May;25(2):202–207. doi: 10.1093/oxfordjournals.bmb.a070693. [DOI] [PubMed] [Google Scholar]
  88. Pool J. G., Shannon A. E. Production of high-potency concentrates of antihemophilic globulin in a closed-bag system. N Engl J Med. 1965 Dec 30;273(27):1443–1447. doi: 10.1056/NEJM196512302732701. [DOI] [PubMed] [Google Scholar]
  89. Pool J. G., Welton J., Creger W. P. Ineffectiveness of intramuscularly injected Factor 8 concentrate in two hemophilic patients. N Engl J Med. 1966 Sep 8;275(10):547–548. doi: 10.1056/NEJM196609082751009. [DOI] [PubMed] [Google Scholar]
  90. Prentice C. R., Breckenridge R. T., Forman W. B., Ratnoff O. D. Treatment of haemophilia (factor-8 deficiency) with human antihaemophilic factor prepared by the cryoprecipitate process. Lancet. 1967 Mar 4;1(7488):457–460. doi: 10.1016/s0140-6736(67)91087-2. [DOI] [PubMed] [Google Scholar]
  91. Prince A. M. The high voltage immunoelectroosmophoretic (IEOP) technique for detection of SH antigen: application to blood donor screening and to study of liver disease. Vox Sang. 1970 Sep-Oct;19(3):205–210. [PubMed] [Google Scholar]
  92. Rabiner S. F., Telfer M. C. Home transfusion for patients with hemophilia A. N Engl J Med. 1970 Nov 5;283(19):1011–1015. doi: 10.1056/NEJM197011052831902. [DOI] [PubMed] [Google Scholar]
  93. Recent developments in blood components therapy. Ann Intern Med. 1971 Jan;74(1):113–125. doi: 10.7326/0003-4819-74-1-113. [DOI] [PubMed] [Google Scholar]
  94. Redeker A. G., Hopkins C. E., Jackson B., Peck P. A controlled study of the safety of pooled plasma stored in the liquid state at 30-32 C for six months. Transfusion. 1968 Mar-Apr;8(2):60–64. doi: 10.1111/j.1537-2995.1968.tb02396.x. [DOI] [PubMed] [Google Scholar]
  95. Rizza C. R. The management of haemophilia. Practitioner. 1970 Jun;204(224):763–772. [PubMed] [Google Scholar]
  96. Roberts L. No therapeutic use for fibrinogen. N Engl J Med. 1971 Jan 28;284(4):218–218. doi: 10.1056/NEJM197101282840416. [DOI] [PubMed] [Google Scholar]
  97. Rowe A. W., Eyster E., Kellner A. Liquid nitrogen preservation of red blood cells for transfusion; a low glycerol-rapid freeze procedure. Cryobiology. 1968 Sep-Oct;5(2):119–128. doi: 10.1016/s0011-2240(68)80154-3. [DOI] [PubMed] [Google Scholar]
  98. SHIRES T. THE ROLE OF SODIUM-CONTAINING SOLUTIONS IN THE TREATMENT OF OLIGEMIC SHOCK. Surg Clin North Am. 1965 Apr;45:365–376. doi: 10.1016/s0039-6109(16)37537-5. [DOI] [PubMed] [Google Scholar]
  99. STRUMIA M. M., BURNS M. E., SAMPLE A. B., McGRAW J. J., Jr The incidence of posttransfusion hepatitis. II. A 13-year survey including 2 years during which blood donors were screened by means of liver function studies. Am J Clin Pathol. 1958 Aug;30(2):133–142. doi: 10.1093/ajcp/30.2.133. [DOI] [PubMed] [Google Scholar]
  100. Schmitt H. Indications and clinical effect of fibrinogen preparations. Vox Sang. 1969 Apr;16(4):412–417. [PubMed] [Google Scholar]
  101. Schmitt H. Indications and clinical effect of fibrinogen preparations. Vox Sang. 1969 Apr;16(4):412–417. [PubMed] [Google Scholar]
  102. Schroeder D. D., Mozen M. M. Australia antigen: distribution during Cohn ethanol fractionation of human plasma. Science. 1970 Jun 19;168(3938):1462–1464. doi: 10.1126/science.168.3938.1462. [DOI] [PubMed] [Google Scholar]
  103. Schwarzenberg L., Mathe G. White cell transfusions: six years experience. Br J Haematol. 1969 Dec;17(6):603–604. [PubMed] [Google Scholar]
  104. Shields C. E., Bunn H. F., Litwin S. D., Reed L. J., Dauber L. G. Clinical evaluation of transfused blood after long-term storage in ACD with adenine. Transfusion. 1969 Sep-Oct;9(5):246–250. doi: 10.1111/j.1537-2995.1969.tb04931.x. [DOI] [PubMed] [Google Scholar]
  105. Shields C. E. Comparison studies of whole blod stored in ACD and CPD and with adenine. Transfusion. 1968 Jan-Feb;8(1):1–8. [PubMed] [Google Scholar]
  106. Shields C. E., Lopas H., Birndorf N. I. Investigation of nephrotoxic effects of adenine and its metabolic product, 2,8-dioxyadenine, on primates (Macaca irus). J Clin Pharmacol J New Drugs. 1970 Sep-Oct;10(5):316–322. doi: 10.1177/009127007001000505. [DOI] [PubMed] [Google Scholar]
  107. Silver H., Sonnenwirth A. C., Beisser L. D. Bacteriologic study of platelet concentrates prepared and stored without refrigeration. Transfusion. 1970 Nov-Dec;10(6):315–316. doi: 10.1111/j.1537-2995.1970.tb00750.x. [DOI] [PubMed] [Google Scholar]
  108. Strumia M. M., Strumia P. V., Eusebi A. J. The preservation of blood for transfusion. 8. Effect of adenine and inosine on the adenosine triphosphate and viability of red cells of blood stored at 1 degree C. for 21 days. J Lab Clin Med. 1970 Dec;76(6):907–914. [PubMed] [Google Scholar]
  109. Strumia M. M., Strumia P. V. Transfusion of long stored whole blood or washed red blood cells incubated with adenine and inosine. Transfusion. 1971 Sep-Oct;11(5):258–265. doi: 10.1111/j.1537-2995.1971.tb04412.x. [DOI] [PubMed] [Google Scholar]
  110. Sumida S., Okuyama Y., Kamegai T. Serum-Hepatitis from frozen blood. Lancet. 1967 Dec 9;2(7528):1255–1256. doi: 10.1016/s0140-6736(67)90595-8. [DOI] [PubMed] [Google Scholar]
  111. Sutnick A. I., London W. T., Blumberg B. S. Australia antigen: a genetic basis for chronic liver disease and hepatoma? Ann Intern Med. 1971 Mar;74(3):443–444. [PubMed] [Google Scholar]
  112. Tavenner R. W. Epsilon-aminocaproic acid in the treatment of haemophilia and Christmas disease with special reference to the extraction of teeth. Br Dent J. 1968 Jan 2;124(1):19–22. [PubMed] [Google Scholar]
  113. Tovey G. H. Immunological problems of the multi-transfused patient. Br J Haematol. 1969 Dec;17(6):604–605. [PubMed] [Google Scholar]
  114. Tullis J. L., Hinman J., Sproul M. T., Nickerson R. J. Incidence of posttransfusion hepatitis in previously frozen blood. JAMA. 1970 Oct 26;214(4):719–723. [PubMed] [Google Scholar]
  115. Valeri C. R. Frozen blood (concluded). N Engl J Med. 1966 Aug 25;275(8):425–concl. doi: 10.1056/NEJM196608252750806. [DOI] [PubMed] [Google Scholar]
  116. Valeri C. R. Frozen blood. N Engl J Med. 1966 Aug 18;275(7):365–373. doi: 10.1056/NEJM196608182750706. [DOI] [PubMed] [Google Scholar]
  117. Valeri C. R., McCallum L. E., Danon D. Relationship between in vivo survival and (1) density distribution, (2) osmotic fragility of previously frozen, autologous, agglomerated, deglycerolized erythrocytes. Transfusion. 1966 Nov-Dec;6(6):554–564. doi: 10.1111/j.1537-2995.1966.tb04778.x. [DOI] [PubMed] [Google Scholar]
  118. Valeri C. R., Szymanski I. O., Runck A. H. Therapeutic effectiveness of homologous erythrocyte transfusions following frozen storage at --80 C for up to seven years. Transfusion. 1970 May-Jun;10(3):102–112. doi: 10.1111/j.1537-2995.1970.tb00716.x. [DOI] [PubMed] [Google Scholar]
  119. Valeri C. R. Viability and function of preserved red cells. N Engl J Med. 1971 Jan 14;284(2):81–88. doi: 10.1056/NEJM197101142840205. [DOI] [PubMed] [Google Scholar]
  120. Vyas G. N., Munver U. L., Salgaonkar D. S., Purandare N. M. Human cadaver blood for transfusion. Transfusion. 1968 Jul-Aug;8(4):250–253. doi: 10.1111/j.1537-2995.1968.tb02417.x. [DOI] [PubMed] [Google Scholar]
  121. Webster W. P., Roberts H. R., Thelin G. M., Wagner R. H., Brinkhous K. M. Clinical use of a new glycine-precipitated antihemophilic fraction. Am J Med Sci. 1965 Dec;250(6):643–651. doi: 10.1097/00000441-196512000-00005. [DOI] [PubMed] [Google Scholar]
  122. Weil M. H. Red blood cell transfusions. JAMA. 1970 Sep 21;213(12):2081–2081. [PubMed] [Google Scholar]
  123. White J. G., Krivit W. An ultrastructural basis for the shape changes induced in platelets by chilling. Blood. 1967 Nov;30(5):625–635. [PubMed] [Google Scholar]
  124. Wilson J. D., Taswell H. F. Autotransfusion: historical review and preliminary report on a new method. Mayo Clin Proc. 1968 Jan;43(1):26–35. [PubMed] [Google Scholar]
  125. Wilson J. D., Taswell H. F., Utz D. C. Autotransfusion: urologic applications and the development of a modified irrigating fluid. J Urol. 1971 Jun;105(6):873–877. doi: 10.1016/s0022-5347(17)61651-3. [DOI] [PubMed] [Google Scholar]
  126. Wilson R. F., Mammen E., Walt A. J. Eight years of experience with massive blood transfusions. J Trauma. 1971 Apr;11(4):275–285. doi: 10.1097/00005373-197104000-00001. [DOI] [PubMed] [Google Scholar]
  127. Yankee R. A., Grumet F. C., Rogentine G. N. Platelet transfusion The selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing. N Engl J Med. 1969 Nov 27;281(22):1208–1212. doi: 10.1056/NEJM196911272812202. [DOI] [PubMed] [Google Scholar]
  128. Zucker M. B., Pert J. H., Lundberg A., Yankee R. A., Henderson E. S. Preservation and clinical use of platelets. Vox Sang. 1969 Apr;16(4):373–381. [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES